| Prev Close: | 47.37 |
|---|---|
| Open: | 47.28 |
| Bid: | 46.55 x 900 |
| Ask: | 48.40 x 900 |
| NAV¹: | 46.27 |
| Net Assets²: | 215.62M |
| YTD Return (Mkt)²: | 13.42% |
| Day's Range: | 46.99 - 47.51 |
|---|---|
| 52wk Range: | 36.05 - 48.16 |
| Volume: | 41,961 |
| Avg Vol (3m): | 75,359 |
| P/E (ttm)²: | 15 |
| Yield (ttm)²: |
¹As of Apr 21, 2013
²As of Mar 30, 2013
Headlines
- [video] Bioterrorism Profitsat CNBC(Mon, May 20)
- [video] Faber Report: Royalty Pharma to Raise Elan Bidat CNBC(Mon, May 20)
- [video] What's Working in Pharmaat CNBC(Mon, May 13)
- [video] No Huddle Offense: What's Working In Pharmaat CNBC(Fri, May 3)
- [video] You Ask, Cramer Answers! Buy Trius?at CNBC(Fri, May 3)
- PPH, SNY, GSK, AZN: ETF Outflow Alertat Forbes(Fri, May 3)
- [video] Charles River CEO: Had a Negligible Impact From Sequesterat CNBC(Thu, May 2)
- [video] Talking Numbers: Pfizer Flops Earningsat CNBC(Tue, Apr 30)
- Tuesday's ETF with Unusual Volume: PPHat Forbes(Tue, Apr 30)
- [video] Novartis Disputes Allegationsat CNBC(Mon, Apr 29)
- [video] Most Undervalued Pharma Stock Is Merck: Proat CNBC(Mon, Apr 29)
- [video] Isis Takes on Huntington's Diseaseat CNBC(Wed, Apr 24)
- PPH, SNY, GSK, AZN: ETF Inflow Alertat Forbes(Tue, Apr 16)
- [video] Acorda CEO: Ampyra Helping Stroke Victims Walk Betterat CNBC(Mon, Apr 15)
- [video] Cramer: Yes, I Like Pfizerat CNBC(Fri, Apr 12)
Reports
- PHARMACEUTICAL HOLDRS TR (PPH) 12-months forecastPechala's Reports(May 25)
- PHARMACEUTICAL HOLDRS TR (PPH) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)
- Priceless Piranha Capital Corp (PPH.P) Profile and Financials, plus Investments...Plunkett Research, Ltd.(May 14)
